외과계 중환자실의 약물-영양 상호작용과 배합적합성에 대한 처방 현황 및 약물 조정의 영향 평가
Interaction and Compatibility Between Parenteral Administration of Drugs and Nutrient in the Surgical Intensive Care Unit: Effects of Clinical Pharmacist Interventions
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Patients in surgical intensive care unit (SICU) commonly receive numerous intravenous drugs and are supported by parenteral nutrition. Thus, patients are often exposed to drug-nutrient interactions and incompatibilities. Compatibility issues with parenteral administrations are crucial for practitioners as it could impact clinical outcomes. The purpose of this study was to evaluate the appropriateness of drug administration by investigating drug-nutrient interactions and compatibility and to assess drug users’ recognition and experiences related with ICU pharmacist services. Methods : A retrospective evaluation of drugs and nutrients in all prescriptions of patients admitted to the SICU during June 2017 was performed using electronic medical records. Then, in from September to October 2017, the drug administration routes were checked in patients who received total parenteral nutrition (TPN) in the ICU and drug adjustments were performed if the combination was inappropriate. Questionnaires were distributed to SICU nurses responsible for administering drugs for one week to assess the recognition and required pharmacy service regarding drug-nutrient compatibility. Results : In this study, 247 intravenous drug-nutrient interactions were identified from 18,350 combinations between drugs and nutrients. Fifteen interactions were recorded as “consideration of therapeutic correction” by the Lexicomp online® standard and all were interactions between calcium and ceftriaxone. The drug route study revealed 18 incompatibilities in intravenous drug-nutritional combinations, of which were ‘no concomitant data’ on the basis of the Lexicomp online®. In the nurses’ questionnaire conducted after the pharmacists’ interventions, 86.7% were aware of Y-site incompatible drugs and 16.7% experienced witnessing sedimentation or foreign materials. The required clinical pharmacy service was easy access to acquire information regarding compatibility. Conclusion : Findings from our study show that pharmacists’ interventions were necessary to determine drug modification of drugs or routes of drug administration. Additionally, the questionnaire confirmed the need for development of information access services regarding drug administration.
Abstract
Background : Patients in surgical intensive care unit (SICU) commonly receive numerous intravenous drugs and are supported by parenteral nutrition. Thus, patients are often exposed to drug-nutrient interactions and incompatibilities. Compatibility issues with parenteral administrations are crucial for practitioners as it could impact clinical outcomes. The purpose of this study was to evaluate the appropriateness of drug administration by investigating drug-nutrient interactions and compatibility and to assess drug users’ recognition and experiences related with ICU pharmacist services. Methods : A retrospective evaluation of drugs and nutrients in all prescriptions of patients admitted to the SICU during June 2017 was performed using electronic medical records. Then, in from September to October 2017, the drug administration routes were checked in patients who received total parenteral nutrition (TPN) in the ICU and drug adjustments were performed if the combination was inappropriate. Questionnaires were distributed to SICU nurses responsible for administering drugs for one week to assess the recognition and required pharmacy service regarding drug-nutrient compatibility. Results : In this study, 247 intravenous drug-nutrient interactions were identified from 18,350 combinations between drugs and nutrients. Fifteen interactions were recorded as “consideration of therapeutic correction” by the Lexicomp online® standard and all were interactions between calcium and ceftriaxone. The drug route study revealed 18 incompatibilities in intravenous drug-nutritional combinations, of which were ‘no concomitant data’ on the basis of the Lexicomp online®. In the nurses’ questionnaire conducted after the pharmacists’ interventions, 86.7% were aware of Y-site incompatible drugs and 16.7% experienced witnessing sedimentation or foreign materials. The required clinical pharmacy service was easy access to acquire information regarding compatibility. Conclusion : Findings from our study show that pharmacists’ interventions were necessary to determine drug modification of drugs or routes of drug administration. Additionally, the questionnaire confirmed the need for development of information access services regarding drug administration.
참고문헌 (21)
- Moyen E, "Clinical review : Medication errors in critical care : review", Critical Care, 12(2), pp.208~215 (2008)
- Jeejeebhoy, "Parenteral nutrition in the intensive care unit", Nutrition Reviews, 70(11), pp.623~630 (2012)
- Tatiane Heldt, "Drug-nutrient interactions in the intensive care unit : literature review and current recommendations", Revista Brasileira de terapia intensive, 25(2), pp.162~167 (2013)
- Laura M. Fox, "Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration", American Journal of Health-System Pharmacy, 70(6), pp.520~524 (2013)
- Joseph I. Boullata, "Drug–Nutrient Interactions : A Broad View with Implications for Practice", Journal of the Academy of Nutrition and Dietetics, 112(4), pp.506~517 (2012)
- Joanna E Klopotowska, "On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm : an intervention study", Critical Care, 14(5), pp.174~186 (2010)
- 정정원, "외과계 중환자실 약사의 처방중재효과 평가", 병원약사회지, 31(4), pp.908~918 (2014), 한국병원약사회[DOI]
- 신상미, "외과계 중환자실 전담약사 유무에 따른 중재활동 변화 및 회피비용 분석", 병원약사회지, 34(4), pp.401~409 (2017), 한국병원약사회[DOI]
- 최재희, "내과계 중환자실 약료 서비스 도입과 약물상호작용 모니터링", 한국임상약학회지, 25(3), pp.138~144 (2015), 한국임상약학회
- 김지나, "소아중환자실에서의 약물상호작용 평가", 병원약사회지, 33(2), pp.122~129 (2016), 한국병원약사회[DOI]
- Hasan SS, "Impact of pharmacists’ intervention on identification and management of drug -drug interactions in an intensive care setting", Singapore Med J, 53(8), pp.526~531 (2012)
- Smithburger PL, "Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved", Int. J Pharm Pract, 20(6), pp.402~408 (2012)
- Ondrej Machotka, "Incidence of intravenous drug incompatibilities in intensive care units", Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 159(4), pp.652~656 (2015)
- Gaetani Melany, "Concurrent intravenous drug administration to critically ill children : Evaluation of frequency and compatibility", Journal of Critical Care, 41, pp.198~203 (2017)
- Staven Vigdis, "Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs", Nutrition Journal, 15, pp.29~ (2016)
- Miranda Talita Muniz Maloni, "Compatibility : drugs and parenteral nutrition", Einstein(Sao Paulo, Brazil), 14(1), pp.52~55 (2016)
- Aygin Bayraktar Ekincioğlu, "Clinical nutrition and drug interactions", Ulusal Cer Derg, 29(4), pp.177~186 (2013)
- Emily Steadman, "Evaluation of a Potential Clinical Interaction between ceftriaxone and Calcium", Antimicrobial agents and chemotherapy, 54(4), pp.1534~1540 (2010)
- Alfred Gin, "Notice to Hospitals Regarding ceftriaxone–Calcium Incompatibility : What’s a Clinician to Do", CJHP, 62(2), pp.157~158 (2009)
- Hillel Halkin, "Preventing drug interactions by online prescription screening in community pharmacies and medical practices", Clinical pharmacology and therapeutics, 69(4), pp.260~265 (2001)